1000/1000
Hot
Most Recent
| Version | Summary | Created by | Modification | Content Size | Created at | Operation |
|---|---|---|---|---|---|---|
| 1 | Metting Esther | + 1497 word(s) | 1497 | 2021-11-15 09:27:03 | | | |
| 2 | Beatrix Zheng | Meta information modification | 1497 | 2021-11-19 09:39:08 | | |
Asthma and chronic obstructive pulmonary disease (COPD) are prevalent chronic pulmonary diseases requiring ongoing self-management. According to the World Health Organization, approximately 339 million people worldwide have asthma, and over 65 million suffer from moderate-to-severe COPD, making it the third leading cause of death worldwide. Asthma typically starts early in life and is related to an allergy, whereas COPD is typically caused by air pollutants such as cigarette smoke or biomass fuel.
Assessments by healthcare providers typically only offer a relatively static status of a patient at a given point in time and may not reflect their full range of symptoms and fluctuations. For example, in patients with asthma, it is not uncommon to have a normal lung function and no symptoms during the assessment, while being symptomatic at home [1]. Furthermore, patients may fail to recognize early signs of an exacerbation, leading to delays in consultation, diagnosis and treatment [2][3]. The early detection and intervention of an exacerbation can reduce recovery times and the need for hospitalization, while also improving quality of life (QoL) [3][4][5]. Frequent evaluations of symptoms and clinical parameters also facilitate personalized care, helping to enhance diagnostic accuracy, improve disease management and prevent exacerbations. However, healthcare providers already have a high workload [6], and increasing the number of clinical visits and assessments is undesirable.
Technological advancements have produced convenient and affordable tools for monitoring symptoms, including Bluetooth ® blood pressure devices, oximeters and mini spirometers. In addition, patients are increasingly able to access the internet, and healthcare providers and organizations are increasingly able to exchange medical data safely within specific digital environments. These developments have led to innovative possibilities for diagnosing, monitoring and treating patients with asthma or COPD. An example of this is telemonitoring. It allows patients to monitor their symptoms and physical parameters at home, share the data with healthcare providers and receive tailored treatment strategies based on that information. In this way, technology can support healthcare providers to deliver personalized disease management and more frequent symptom monitoring without the need for clinical visits or physical on-site assessments [7][8].
Telemonitoring can empower patients to become more actively involved in managing their asthma or COPD [9][10]. Numerous studies have shown that self-management is difficult and often poor in these groups, with an estimated 22–78% of patients having poor adherence to medical therapies [11]. Furthermore, incorrect inhaler technique is common [12], and 30–50% of symptomatic patients continue to smoke despite moderate-to-severe COPD [13]. Education can improve self-management skills and enhance disease control [14][15]. Thus, telemonitoring enables patients to be actively involved in their disease management and provides time-efficient education and feedback.
International asthma and COPD guidelines, such as the Global Initiative for Asthma (GINA) and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) [16][17], acknowledge the potential of telemonitoring in disease management. Telemonitoring may offer benefits to disease status [18], health-related QoL (HR-QoL) [18][19], exacerbations [19], hospital admissions [19], exercise capacity [18][20] and healthcare utilization (including emergency room visits) [21]. To date, the considerable heterogeneity in the research methodology, monitoring devices, outcome variables and patient populations in studies of telemonitoring make it difficult to draw firm conclusions regarding its effectiveness [7][22][23] and feasibility [24] for these diseases. Implementing telemonitoring in healthcare can also be complicated by organizational limitations, technical matters and resistance from potential users [25]. Acceptance by stakeholders, integration in electronic health records and cost-effectiveness in comparison to current treatment are key to successful implementation. Many promising eHealth technologies have failed to realize their potential to improve outcomes due to resistance from healthcare providers or patients [25][26].
Telemonitoring is effective, feasible and safe compared to care as usual for patients with COPD. There was an insufficient number of studies to draw conclusions regarding asthma telemonitoring. Telemonitoring can improve several clinical outcomes in COPD patients, including the need for hospitalization, length of hospitalization, number of clinical visits, QoL and number of exacerbations. Adding an educational element to a telemonitoring intervention seems to increase the prospect of a positive effect. However, there is a lack of research on the behavioral and process factors related to telemonitoring. Future research should focus on the effects of telemonitoring in patients with asthma, the full telemonitoring process for the patient and the healthcare provider and its implementation in the healthcare organization, as well as the impact of patient and healthcare provider characteristics.